Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Corpuscle01:20

Renal Corpuscle

9.8K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
9.8K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

1.1K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.1K
Nephrons01:10

Nephrons

10.0K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
10.0K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

387
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
387
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

1.4K
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
1.4K
Diabetic Nephropathy01:28

Diabetic Nephropathy

2
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
2

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancy outcome in patients with a medical history of immunoglobulin A vasculitis: a case-control study.

Scandinavian journal of rheumatology·2023
Same author

Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases.

Clinical rheumatology·2023
Same author

French practical guidelines for the diagnosis and management of AA amyloidosis.

La Revue de medecine interne·2023
Same author

Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.

Scandinavian journal of rheumatology·2021
Same author

Disease severity of proliferative lupus nephritis in Maghrebians.

Lupus·2018
Same author

Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients.

Leukemia·2016

Related Experiment Video

Updated: Apr 20, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.7K

[Lupus nephritis: up-to-date].

A Karras1

  • 1Service de néphrologie, hôpital européen Georges-Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris, France.

La Revue De Medecine Interne
|December 3, 2014
PubMed
Summary
This summary is machine-generated.

Systemic lupus erythematosus (SLE) frequently affects the kidneys, with proliferative lupus nephritis (LN) being severe. Early screening and renal biopsy guide treatment, aiming for remission and reduced cardiovascular risks.

Keywords:
GlomerulonephritisGlomérulonéphriteImmunosuppressionLupus nephritisNéphropathie lupique

More Related Videos

Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

194
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

19.2K

Related Experiment Videos

Last Updated: Apr 20, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.7K
Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

194
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

19.2K

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Renal involvement is common in systemic lupus erythematosus (SLE) and significantly impacts prognosis.
  • Kidney disease in SLE requires regular screening for proteinuria, hematuria, and renal failure.
  • Active glomerulonephritis (GN) necessitates renal biopsy to guide therapeutic decisions.

Purpose of the Study:

  • To review the significance of renal involvement in SLE.
  • To discuss diagnostic approaches and treatment strategies for lupus nephritis (LN).
  • To highlight the prognostic value and management of proliferative LN.

Main Methods:

  • Literature review of SLE natural history and renal manifestations.
  • Analysis of diagnostic criteria and histopathological classifications for LN.
  • Summary of current and emerging therapeutic options for proliferative LN.

Main Results:

  • Proliferative GN (class III/IV) is the most severe form of LN, potentially leading to end-stage renal disease (ESRD).
  • Standard induction therapy involves corticosteroids and immunosuppressants like cyclophosphamide or mycophenolate mofetil (MMF).
  • Maintenance therapy with azathioprine or MMF is crucial to prevent relapses.

Conclusions:

  • Effective management of proliferative LN is critical for preventing ESRD and improving patient outcomes.
  • Newer biotherapies are under investigation to enhance remission rates and minimize corticosteroid toxicity.
  • Cardiovascular disease is a major cause of mortality in SLE patients with kidney disease, underscoring the need for comprehensive management.